ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 87 filers reported holding ADICET BIO INC in Q2 2024. The put-call ratio across all filers is 8.44 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $441,011 | -48.5% | 364,472 | 0.0% | 0.11% | +478.9% |
| Q1 2024 | $856,509 | -34.2% | 364,472 | -47.1% | 0.02% | -36.7% |
| Q4 2023 | $1,301,445 | +30.3% | 688,595 | -5.5% | 0.03% | -91.8% |
| Q3 2023 | $998,653 | -43.6% | 728,944 | 0.0% | 0.37% | -33.1% |
| Q2 2023 | $1,771,334 | -57.8% | 728,944 | 0.0% | 0.55% | -59.7% |
| Q1 2023 | $4,198,717 | +64327.1% | 728,944 | 0.0% | 1.37% | -28.0% |
| Q4 2022 | $6,517 | -99.9% | 728,944 | 0.0% | 1.90% | -37.8% |
| Q3 2022 | $10,366,000 | -2.6% | 728,944 | 0.0% | 3.05% | +12.2% |
| Q2 2022 | $10,643,000 | -26.9% | 728,944 | 0.0% | 2.72% | -1.2% |
| Q1 2022 | $14,557,000 | +14.2% | 728,944 | 0.0% | 2.75% | +89.7% |
| Q4 2021 | $12,749,000 | +123.1% | 728,944 | 0.0% | 1.45% | +189.6% |
| Q3 2021 | $5,715,000 | – | 728,944 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $18,911,542 | 6.16% |
| Foresite Capital Management V, LLC | 558,636 | $4,994,206 | 3.88% |
| COWEN AND COMPANY, LLC | 3,143,608 | $28,103,855 | 2.94% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $5,185,200 | 1.94% |
| JOHNSON & JOHNSON | 728,944 | $6,517 | 1.90% |
| DAFNA Capital Management LLC | 631,554 | $5,646,093 | 1.59% |
| Orbimed Advisors | 7,447,140 | $66,577,432 | 1.27% |
| EcoR1 Capital, LLC | 3,560,700 | $31,832,658 | 0.97% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $5,364,000 | 0.78% |
| RTW INVESTMENTS, LP | 4,241,472 | $37,918,760 | 0.77% |